-

OBIO’s Health to Business Bridge Program (H2BB) is Preparing the Future Leaders of Ontario’s Health Science Industry

TORONTO--(BUSINESS WIRE)--OBIO’s Health to Business Bridge™ Program (H2BB) prepares new hires for careers in Ontario’s health science industry, helping companies build for the future in an innovative sector poised for growth.

As we all work to combat the impact of COVID-19, health science companies in Ontario continue to innovate. These companies are progressing and hiring new employees who are knowledgeable, adaptable, and ready to contribute.

H2BB has a proven track record of bringing early career talent up-to-speed quickly, through a combination of industry-specific training and pairing candidates with expert advisors. Already in 2020, OBIO H2BB has 35 new hires from 16 growing companies enrolled in its industry-specific training courses.

“By supporting programs like OBIO’s Health to Business Bridge Program, our government is helping develop the talent that will lead our future economy,” said Monte McNaughton, Minister of Labour, Training and Skills Development. “Ontario’s innovative health science industry is an important part of that future and we are proud to help people prepare for good jobs and exciting, fulfilling careers.”

OBIO H2BB: Preparing New Hires to Adapt and Contribute

Health science companies with new hires in H2BB recognize the value of getting new hires up to speed quickly. “Cohesys enrolled two employees in H2BB this year and both individuals are applying what they have learned through the H2BB training to their work at Cohesys,” said Mike Tessier, COO and Co-Founder of Cohesys, an OBIO Member. “We are looking forward to enrolling additional employees in the near term.”

Epineuron has enrolled additional new hires after the company’s first H2BB participant spoke about the direct applicability of the program’s training. “What we heard from Epineuron’s first candidate in the H2BB program was that the training was especially relevant for someone who was new to the health science industry,” said Mike Willand, Co-Founder and CTO of Epineuron, an OBIO Member.

H2BB participants point out how the design of the program helps them accumulate knowledge and skills quickly to make an impact. “The H2BB program provided a great opportunity for me to learn all the processes involved in transforming an idea into a commercial product – which is exactly what I needed to know,” said Goli Ameri, Senior R&D Engineer at COSM.

OBIO: Positioning the Health Science Industry for Success

Through H2BB and all its programs like CAAP®, HealthMINT™ and EAHN™, OBIO is growing jobs in the health science industry and preparing the leaders of tomorrow’s industry.

With renewed focus on innovative health technology as part of global economic recovery, OBIO is advancing key programs positioning Ontario to be a leader. As the health science industry responds to the COVID-19 pandemic, OBIO has responded in kind. OBIO’s EAHN has issued a call for applications from companies to address COVID-19.

To find out more about how H2BB can help your company develop new hires, contact Andreea Norman at andreeanorman@obio.ca. To find out how your company can build Ontario’s health science industry with OBIO, contact Grant Burns at grantburns@obio.ca.

OBIO Health to Business Bridge Program™

OBIO Health to Business Bridge™ program (H2BB) has a proven track record in bringing early career talent up-to-speed quickly and giving them a solid footing in the fundamentals of the health science industry. H2BB provides pre-screened candidates, advisors and training for all early career roles, including business, quality, regulatory and R&D, with the support of Employment Ontario.

About OBIO

OBIO®, founded in 2009, is a not-for-profit, membership-based innovation organization engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies positioning Canada as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.

Contacts

Grant Burns
Vice President, Public Affairs and Communications, OBIO
grantburns@obio.ca

Industry:

OBIO

Release Summary
OBIO’s H2BB program prepares new hires for careers in Ontario’s health science industry, helping companies build for the future.
Release Versions
English
Hashtags
#healthscience

Contacts

Grant Burns
Vice President, Public Affairs and Communications, OBIO
grantburns@obio.ca

More News From OBIO

St. Joseph’s Healthcare Hamilton Adopts Made-in-Canada Technology for Real-Time Equipment Tracking and Improved Patient Experience

WATERLOO, Ontario & HAMILTON, Ontario--(BUSINESS WIRE)--Studies across the world have shown that, on average, hospitals tend to use less than half of their medical assets at any given time. In addition, hospitals are likely to hold on average three times as much inventory as they need. In a facility the size of St. Joseph’s Healthcare Hamilton Charlton Campus (St. Joe’s), which has 600 beds, specialized equipment such as mattresses designed to reduce pressure sores and IV poles travel with pati...

Canadian-Made Technology Gives Hospital Teams Clearer Images at the Bedside

TORONTO--(BUSINESS WIRE)--Each year, more than 20 million diagnostic X-ray procedures are performed in Canada according to Health Canada. While regular X-rays are used every day in hospitals, they sometimes miss important details – depending on the case and imaging conditions. That’s because bones and other body parts can overlap in the images. In collaboration with OBIO®, University Health Network (UHN), Canada’s leading hospital and the No. 1 publicly funded hospital in the world, is adding a...

OBIO® Drives AI Innovation in Critical Care with The Ottawa Hospital’s Use of the Extubation Advisor

TORONTO--(BUSINESS WIRE)--OBIO®, through its Life Sciences Critical Technology and Commercialization (LSCTC) Centre for Excellence, is supporting the adoption of the Extubation Advisor (EA) at The Ottawa Hospital (TOH). Developed by Canadian company Therapeutic Monitoring Systems Inc. (TMS), this AI-powered clinical support tool is designed to assist clinicians in making extubation decisions in intensive care units. The EA was adopted after successful evaluations were completed at TOH and Unity...
Back to Newsroom